Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Age-Related Osteoporosis

dabigatran has been researched along with Age-Related Osteoporosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Alonso, A; Chen, LY; Diem, SJ; Ensrud, KE; Lutsey, PL; MacLehose, RF; Norby, FL1
Hsu, JY; Huang, HK; Lin, SM; Liu, PP; Loh, CH; Peng, CC; Wang, JH; Yeh, JI1
Bilen, O; Teruya, J1
Nendaz, M; Perrier, A1

Reviews

1 review(s) available for dabigatran and Age-Related Osteoporosis

ArticleYear
Complications of anticoagulation.
    Disease-a-month : DM, 2012, Volume: 58, Issue:8

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Contamination; Drug Monitoring; Food-Drug Interactions; Hemorrhage; Heparin; Humans; Hypersensitivity; Injections, Subcutaneous; Necrosis; Osteoporosis; Skin Diseases; Subcutaneous Tissue; Thrombocytopenia; Warfarin

2012

Other Studies

3 other study(ies) available for dabigatran and Age-Related Osteoporosis

ArticleYear
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
    JAMA internal medicine, 2020, 02-01, Volume: 180, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Comorbidity; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Female; Fractures, Bone; Hip Fractures; Hospitalization; Humans; Incidence; Male; Middle Aged; Osteoporosis; Proportional Hazards Models; Protective Factors; Pyrazoles; Pyridones; Rivaroxaban; Warfarin

2020
Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
    Journal of the American Heart Association, 2020, 01-21, Volume: 9, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Databases, Factual; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Osteoporosis; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Taiwan; Treatment Outcome; Warfarin

2020
[Update in hospital internal medicine (2007): a selection].
    Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142

    Topics: Anti-Bacterial Agents; Anticoagulants; Benzimidazoles; Bone Density Conservation Agents; Community-Acquired Infections; Coronary Disease; Dabigatran; Defibrillators, Implantable; Diabetes Mellitus, Type 2; Fractures, Bone; Heart Failure; Heart Neoplasms; Hip Prosthesis; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Internal Medicine; Liver Cirrhosis; Oligosaccharides; Osteoporosis; Peritonitis; Pneumonia, Bacterial; Pulmonary Embolism; Pyridines; Quality of Health Care; Risk Factors; Stroke; Teaching; Tomography, X-Ray Computed; Venous Thrombosis

2008